Clinical Trial Eligibility: Inclusion and Exclusion Criteria Explained

Clinical trial eligibility criteria determine who can and cannot participate in a study. Inclusion criteria are the characteristics that qualify someone; exclusion criteria are the characteristics that disqualify. Together, they exist to produce a study population that lets researchers draw meaningful conclusions about the treatment, with participant safety and ethics guiding which people are excluded. Understanding clinical trial eligibility helps you evaluate whether you might qualify, contact study coordinators when criteria are ambiguous, and avoid disqualifying yourself by misreading a requirement. This guide covers how eligibility criteria work, why they exist, how screening unfolds, and the rights that protect you as a participant. It is general education, not medical advice – talk with your own doctor before pursuing any trial.

Why eligibility criteria exist

Eligibility criteria serve three main purposes:

Scientific rigor: A more homogeneous study population tends to produce clearer results. If a trial enrolls people who vary widely in disease severity, age, or other conditions, the data becomes harder to interpret. Criteria reduce the variables that could obscure the treatment effect.

Participant safety: Some people are at higher risk for adverse events from an experimental treatment. Excluding them is meant to protect their safety, even when it limits enrollment.

Regulatory and statistical considerations: Trials need adequate statistical power to detect treatment effects. Criteria help ensure participants have measurable disease activity that can demonstrate a response.

The criteria represent a balance between scientific rigor (which favors narrow criteria) and generalizability (which favors broad criteria). Trials with very narrow criteria produce cleaner data that can be harder to apply to real-world patients. Trials with very broad criteria produce more widely applicable data but messier statistical analysis. There is a growing effort across the research community to broaden criteria where it is safe to do so, so that trial populations better reflect the patients who will ultimately use a treatment.

Common inclusion criteria

Most trials include some version of:

• Age range: Often 18-75 or 18-65 for adult studies; pediatric studies have their own age ranges
• Sex: Many trials enroll all sexes; some are sex-specific (for conditions specific to women’s or men’s health)
• Disease diagnosis: A confirmed diagnosis of the condition being studied, often with specific severity or duration requirements
• Disease activity measures: Specific ranges for clinical measures (for example, A1c for diabetes, a depression rating scale, or a disability score for MS)
• Stable condition: No recent worsening or acute exacerbation
• Adequate organ function: Lab values within specified ranges for kidney function, liver function, and blood counts
• Ability to comply: Willingness and capacity to complete study visits, take medications as directed, and follow the protocol
• Informed consent: The capacity to provide informed consent (or to have a legally authorized representative do so)

Common exclusion criteria

Standard exclusion categories include:

• Other serious medical conditions: Cancer, severe cardiovascular disease, or advanced kidney or liver disease that could complicate safety or interpretation
• Pregnancy or planned pregnancy: Most trials exclude people who are pregnant or planning pregnancy because effects on a fetus are often unknown
• Recent participation in other trials: Typically a 30-90 day “washout” from prior investigational drugs
• Specific medications: Drugs that could interfere with the study, such as certain anticoagulants or immunosuppressants
• Allergies to study components: Known allergies to the drug class or to inactive ingredients
• Substance use disorder: Active, untreated substance use disorder can affect safety and the ability to follow the protocol; this is a clinical safety consideration, not a judgment about the person
• Certain psychiatric conditions: For example, active suicidal ideation or an unstable psychiatric condition that could make participation unsafe; supportive resources are part of good study conduct
• Recent surgery or hospitalization: Often 30-90 days from major surgery or a hospital admission
• Geographic factors: Living too far from the trial site for the required visits

How to read eligibility criteria

Trial listings on ClinicalTrials.gov include detailed eligibility sections. Read both inclusion and exclusion criteria thoroughly:

1. Start with the high-level criteria (age, condition, geography) – if you do not meet these, there is no need to continue
2. Move to disease-specific criteria – confirmed diagnosis, severity, duration
3. Review lab-value requirements – these often need recent lab work to verify
4. Check medication-related exclusions – note any current medications that might disqualify you
5. Review condition-specific exclusions – other conditions that disqualify
6. Note ambiguous criteria – items where you are not sure whether you qualify

For anything ambiguous, contact the study coordinator before assuming you do not qualify. It also helps to review the listing with your own physician, who can tell you whether a trial fits your situation and whether it is a reasonable option alongside standard care.

Why narrow criteria matter

Trials with narrow criteria can be frustrating for people who appear to “almost qualify.” Common scenarios:

Just outside the age range: A 76-year-old with a relevant condition cannot enroll in a trial limited to ages 18-75.

Slightly outside a lab range: Someone whose A1c is 6.9 may not qualify for a trial requiring 7.0-10.0.

One excluded condition: A person with otherwise good control of several conditions but one specific exclusion (for example, recent breast cancer) may not qualify.

Geographic distance: Someone who would qualify in every other respect lives 200 miles from the nearest site.

These exclusions can feel arbitrary but usually reflect specific scientific or safety considerations. Sometimes coordinators can accommodate minor variations within the protocol; sometimes they cannot. Asking is worth the effort.

How to maximize your trial options

Strategies for finding trials you may qualify for:

• Search broadly first: Cast a wide net with several condition-related searches before filtering aggressively
• Do not self-disqualify: If you appear to meet most criteria, contact the coordinator
• Get current labs: Recent lab work helps confirm whether you meet lab-based criteria
• Document your medication history: A detailed list helps coordinators evaluate eligibility quickly
• Track prior trial participation: Note the dates of any prior trials for washout calculations
• Consider multiple sites: A trial running at several sites may have different practical eligibility (geography, scheduling) at each

The screening visit

If preliminary screening suggests you may qualify, the trial conducts a formal screening visit. Screening typically includes:

• A detailed medical history review
• A physical examination
• Comprehensive lab work to verify lab-based criteria
• An electrocardiogram (ECG) if cardiac safety is relevant
• Imaging if specific imaging is required for entry
• Disease-specific assessments (severity scores, questionnaires, and so on)

Screening often takes a few hours and is conducted at the trial site. Some tests may not be available the same day, so full confirmation of eligibility can take one to two weeks.

Informed consent and your right to withdraw

Before any study procedures begin, you go through informed consent. The research team must explain the study’s purpose, what participation involves, the expected duration, the potential risks and benefits, and any alternatives to participating – including standard treatment outside the trial. You should have time to ask questions and to take the consent document home to review or discuss with your doctor or family. Signing the consent form is not the end of the conversation: consent is an ongoing process, and the team must tell you about new information that could affect your willingness to continue.

Critically, participation is voluntary. You have the right to withdraw from a trial at any time, for any reason, without penalty and without losing access to the regular medical care you are otherwise entitled to. If you have concerns during a study, you can raise them with the study team or with the Institutional Review Board (IRB) that oversees participant protection. According to the NIH and the National Cancer Institute, these protections are core to ethical research.

Research is not guaranteed treatment

It is important to keep expectations realistic. A clinical trial tests something that is not yet proven – the experimental treatment may work, may not work, or may cause side effects. Many trials are randomized, so you might receive the standard treatment or a placebo rather than the investigational option, and you may not know which. Benefit to you personally is never guaranteed. People join trials for different reasons: access to a potential new option, closer monitoring, or contributing to knowledge that helps future patients. All of those are valid, but a trial is not a substitute for a treatment plan you and your doctor have agreed on. Discuss any trial with your own clinician so it fits your overall care.

Screen failures

“Screen failure” is the term for participants who go through screening but do not end up qualifying. Common reasons include lab values outside the required range when measured at screening, disease severity below or above the required range, a condition discovered during screening that was not initially apparent, a concurrent medication that disqualifies, or imaging findings that disqualify. Screen failures are common – often a substantial share of people who pass preliminary screening do not pass full screening. Participants are generally not penalized; they are thanked for their time and may be reimbursed for the screening visit.

Frequently Asked Questions

Can eligibility criteria be modified for me?

Sometimes minor variations are accommodated within the protocol. Major exclusion criteria typically cannot be waived, because doing so could compromise scientific or safety integrity. Ask the coordinator about your specific situation.

What if I am at the edge of an age range?

Some studies are flexible at the edges; others are strict. The coordinator can clarify whether your specific age qualifies. Do not assume the boundary is rigid without asking.

Why are pregnant people usually excluded?

Most experimental drugs have not been studied in pregnancy, and unknown effects on a fetus generally cannot be ethically risked. Pregnancy-specific trials do exist, with extensive protective protocols.

Do I need to disclose all my medications?

Yes. Complete, honest medication disclosure is required for safety and to evaluate eligibility. Leaving something out can be dangerous and may invalidate your participation.

Can I be in multiple trials at once?

Generally no. Most trials exclude concurrent participation in other interventional trials. Observational studies may sometimes be combined with an interventional trial. Confirm with both study teams before enrolling.

Can I leave a trial after I start?

Yes. Participation is voluntary, and you can withdraw at any time without losing your regular medical care. Let the study team know so they can arrange any safety follow-up.

The bottom line on clinical trial eligibility

Eligibility criteria are designed to produce scientifically meaningful and safe trials. They include inclusion criteria that qualify participants and exclusion criteria that disqualify. Reading the criteria carefully helps you avoid self-disqualification, but ambiguous situations should be discussed with study coordinators rather than assumed. Narrow criteria can be frustrating but usually reflect specific considerations. Remember that joining involves informed consent and a right to withdraw, and that a trial is research rather than guaranteed treatment. Resources such as ClinicalTrials.gov, the NIH, the National Cancer Institute, and advocacy organizations can help you find and evaluate options – and your own doctor should be part of the decision.

Sources

• ClinicalTrials.gov (U.S. National Library of Medicine / NIH) – trial listings and eligibility sections (clinicaltrials.gov)
• National Institutes of Health (NIH) – basics of clinical research and informed consent (nih.gov)
• National Cancer Institute (NCI) – clinical trials, eligibility, and informed consent (cancer.gov)